Griffith University’s Institute for Glycomics has been awarded $2.66 million in Ideas Grant funding from the National Health and Medical Research Council (NHMRC) to aid four vital research projects. Director Professor Mark von Itzstein AO was delighted with the grant awards and said they cemented the Institute’s reputation as a leading biomedical research institute. “Our […]
A new experimental drug to treat sepsis has now entered the next stage of clinical trials in patients in Australia after successfully completing Phase 1a trials in healthy volunteers, reports Griffith University’s Institute for Glycomics. The sepsis drug candidate, co-invented by researchers led by Professor Mark von Itzstein AO at the Institute for Glycomics and […]
Dr Lara Herrero, research leader at Griffith University’s Institute for Glycomics, has been honoured with the Creating Change Award at the 2020 Gold Coast Women in Business Awards. The highly prestigious Women in Business Awards of Australia recognises and honours exceptional businesswomen and industry achievers who are making a difference across Queensland. “I am both […]
An experimental Alzheimer's disease treatment is proving effective at treating some of the most persistent, life-threatening antibiotic-resistant bacteria.
Griffith University researchers have discovered a novel approach that could lead to the personalised design of anticancer drugs that resist metastasis (tumour spread) in triple-negative breast cancer. Traditional chemotherapy includes metal-based drugs like Cisplatin, commonly used to treat breast and ovarian cancers. However, many of these traditional chemotherapies have severe side effects and cancers treated […]
A community partnership between Griffith University’s Institute for Glycomics and Sanctuary Cove precinct has raised $31,299 during Breast Cancer Awareness Month to aid vital breast cancer research. A series of pink-themed events and promotions across the month of October were hosted by the Sanctuary Cove precinct to raise funds and awareness for the devastating disease, […]
Partial immunity to SARS-CoV-2 combined with social distancing would significantly reduce mortality rates new mathematical modelling shows.